Marijuana Companies Seek To Defend Trump's Rescheduling Move By Intervening In Opponents' Lawsuits
Key Takeaway
Two medical marijuana companies are taking steps in federal court to intervene in ongoing lawsuits challenging the Trump administration's ongoing cannabis rescheduling process by joining the side of the government and opposing the litigation from prohibitionists. The new motion-filed on Monday by attorneys for MedPharm Iowa, LLC, which does business as Bud & Mary's, and
What This Means for Cannabis Businesses
Tax developments like this directly impact the bottom line for every cannabis operator. With Section 280E creating effective tax rates above 70% for many businesses, any shift in federal tax policy - whether through rescheduling, court rulings, or IRS guidance - can mean the difference between profitability and closure. Cannabis business owners should work closely with a specialized CPA to understand how these changes affect their specific situation.
Find Help
Related News
Virginia Legislature Sends Cannabis Sales Legalization Bill to Governor
Cannabis MSOs Owe $1.6 Billion in Unpaid 280E Taxes as IRS Fights Back
IRS Disputes Cannabis Company's Challenge to 280E in Tax Court
Michigan Cannabis Sales Fall to Lowest Level in Two Years Under New Wholesale Tax
This analysis is based on reporting by Marijuana Moment. Read the original article. CannaBizGuide provides original commentary and analysis - this is not legal or tax advice.